Posterior Instrumented Occipitocervical Fusion in Inflammatory Arthritis

Michael Goytan, M.D., F.R.C.S.C.
Health Sciences Centre
University of Manitoba, Canada
Christine Peschken, M.D., F.R.C.P.C.
Health Sciences Centre
University of Manitoba, Canada
Exhibit from the SRS 2002 Annual Meeting
The outcome of posterior instrumented occipitocervical fusion (PIOF) in eighteen consecutive patients was evaluated. Seventeen patients had rheumatoid arthritis (RA); the other had psoriatic arthritis. Ranawat Grade (RG) before surgery was 2 in 28%, 3a in 55%, and 3b in 17%. Mean Pain Visual Analogue Score (VAS) before surgery was 8.8/10. All patients had an atlantodens interval of > 5mm and vertical migration of the odontoid and 6 patients had posterior atlantodens interval of < 13 mm. Mean follow-up was 24 months (range 3 - 56, one death at 3 months). 78% had a postoperative RG of zero, and 83% had an improvement of at least 2 grades on the RG. Postoperative VAS declined by a mean of 7.8. There were 3 deaths, and 6 complications.

This study supports previous findings that PIOF is a safe and effective procedure for inflammatory arthritis with severe craniocervical involvement.
Last Updated: 04/26/2005